Cytovia Therapeutics Partners with National Cancer Institute to Develop Novel Gene-Edited, iPSC-Derived GPC3 CAR NK Cells for the Treatment of Solid Tumors

    NEXT STORY
    Global UV Sanitizer Travel Wand Market Size, Share & Trends Analysis Report 2020 – 2027
    PREV STORY
    OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Business Update
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Biodesix Confirms Prognostic Value of VeriStrat Testing in Phase 3 Study of Patients with Advanced Lung Cancer

    The Oncologist Publishes Results of 1,048 Patient StudyBOULDER, Colo., Aug. 29, 2018 (GLOBE NEWSWIRE) ...

    author_avatar
    NASDAQ Market News

    New Board starts reviewing the situation in Oasmia

    author_avatar
    NASDAQ Market News

    Data Updates from Ongoing MAGE-A10 Studies and MAGE-A4 Study to be presented at the European Society for Medical Oncology (ESMO) 2018 Congress

    PHILADELPHIA and OXFORD, United Kingdom, Oct. 08, 2018 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc ...

    author_avatar
    NASDAQ Market News